Clinical Trial Update: Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of romosozumab for osteoporosis in postmenopausal women has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Evenity (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Women With Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-12